On July 25, 2023, the Senate voted 91 to 6 to approve the Outbound Investment Transparency Act as an amendment to the National Defense Authorization Act. The legislation was proposed
Continue Reading Congress and the White House May Restrict U.S. Investments in Certain Chinese Industries
On Dec. 11, the House of Representatives passed S. 1790, the National Defense Authorization Act (NDAA) conference report. The Senate followed suit on Dec. 17, bringing an end
Continue Reading Congress Takes Initial Steps to Address PFAS in the National Defense Authorization Act Conference Report
This week Congress finished its work for the year by passing a two-bill package that will avoid a government shutdown and extend several expiring tax provisions. President Trump signed each
Continue Reading Non-Appropriations Provisions of the FY2020 Spending Deal
For a refresher on what Per- and polyfluoroalkyl substances (PFAS) are and what Congressional action may mean for stakeholders, see the Greenberg Traurig E2 Law blog from earlier this year.
Continue Reading PFAS Solution IN (or OUT) of the NDAA?
Every fall there is suspense on Capitol Hill relating to the Congressional agenda. Will Congress fund federal agencies in time to avoid a government shutdown? Which pieces of major legislation
Continue Reading Have You Started Your NDAA Office Pool Yet?
Congress is in the midst of a busy fall dominated by budgetary deadlines and several expiring programs. President Trump recently signed the “Continuing Appropriations Act, 2020, and Health Extenders Act
Continue Reading Deadlines Drive Congressional Agenda
PFAS (perfluoroalkyl and polyfluoroalkyl substances) have been under scrutiny on both sides of the Capitol in recent months, and the Senate made significant headway in late June in reaching consensus
Continue Reading PFAS Solution Moving Through Congress on Must-Pass Defense Bill